Owner Janssen Pharmaceutica N.V.

Inventors Meerpoel, Lieven; Backx, Leo Jacobus Jozef

Agent Shelston IP

Pub. Number AU-B-2002219115

PCT Pub. Number WO02/42271

Priority 00204150.7 21.11.00 EP

Filing date 15 November 2001

Wipo publication date 3 June 2002

Acceptance publication date 4 January 2007

C07D 211/58 (2006.01) Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings

A61K 31/167 (2006.01) - having the nitrogen atom of a carboxamide group directly attached to the aromatic ring, e.g. lidocaine, paracetamol

A61K 31/216 (2006.01)

A61K 31/40 (2006.01) - having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil

A61K 31/4468 (2006.01) - having a nitrogen atom directly attached in position 4, e.g. clebopride, fentanyl

A61P 3/04 (2006.01) Drugs for disorders of the metabolism

A61P 3/06 (2006.01) Drugs for disorders of the metabolism

A61P 3/10 (2006.01) Drugs for disorders of the metabolism

A61P 43/00 (2006.01) Drugs for specific purposes, not provided for in groups

C07C 231/02 (2006.01) Preparation of carboxylic acid amides

C07C 233/80 (2006.01) Carboxylic acid amides

C07C 237/20 (2006.01) Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by amino groups

C07D 207/14 (2006.01) Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom